These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31926488)

  • 1. Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?
    Terada Y; Isaka M; Harada H; Konno H; Kojima H; Mizuno T; Murayama S; Takahashi T; Ohde Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):425-433. PubMed ID: 31926488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
    Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
    Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.
    Borghetti P; Barbera F; Bonù ML; Trevisan F; Ciccarelli S; Vitali P; Maddalo M; Triggiani L; Pasinetti N; Pedretti S; Bonetti B; Pariscenti G; Tironi A; Caprioli A; Buglione M; Magrini SM
    Radiol Med; 2016 Sep; 121(9):696-703. PubMed ID: 27230669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
    Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
    Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for postoperative thoracic lymph node recurrence of non-small-cell lung cancer provides better outcomes if the disease is asymptomatic and a single-station involvement.
    Okami J; Nishiyama K; Fujiwara A; Konishi K; Kanou T; Tokunaga T; Teshima T; Higashiyama M
    J Thorac Oncol; 2013 Nov; 8(11):1417-24. PubMed ID: 24077458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy in radically resected non-small cell lung cancer.
    Mayer R; Smolle-Juettner FM; Szolar D; Stuecklschweiger GF; Quehenberger F; Friehs G; Hackl A
    Chest; 1997 Oct; 112(4):954-9. PubMed ID: 9377958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.
    Taylor NA; Liao ZX; Cox JD; Stevens C; Roth J; Walsh G; Chang JY; Guerrero T; Jeter M; Putnam J; Fossella FV; Allen P; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):204-12. PubMed ID: 14697440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postrecurrence survival in patients with stage I non-small cell lung cancer.
    Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.
    Tandberg DJ; Kelsey CR; D'Amico TA; Crawford J; Chino JP; Tong BC; Ready NE; Wright A
    Clin Lung Cancer; 2017 Jul; 18(4):e259-e265. PubMed ID: 27965012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ; Gee NG; Chino JP; D'Amico TA; Ready NE; Coleman RE; Kelsey CR
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):796-801. PubMed ID: 23870158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
    Imai H; Murakami H; Yoshino R; Mori K; Sumita K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Harada H; Naito T; Kaira K; Tomizawa Y; Ohde Y; Matsuura M; Endo M; Saito R; Nakajima T; Takahashi T
    J BUON; 2016; 21(2):333-40. PubMed ID: 27273942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
    Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of local recurrence and second primary tumors in resected stage I lung cancer.
    Martini N; Bains MS; Burt ME; Zakowski MF; McCormack P; Rusch VW; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):120-9. PubMed ID: 7815787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.